Eli Lilly and Company (LLY) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Eli Lilly and Company, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1,288.30
+0.50% today
Market cap
$1.2T
Overall quality
—
Kronos AI 30-day
−13.5%
0 of 8 simulated paths end higher
Eli Lilly and Company (LLY) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.2T. It trades at $1,288.30, up 0.50% today. 22 analysts' average target of $1,388.25 implies +7.8% from today's price. Kronos AI's 30-day forecast is −13.5% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $1,388.25 |
| Low – high | $940.00 – $1,600.00 |
| Analysts | 22 |
| Upside to average | +7.8% |
Kronos AI 30-day forecast
| Expected close | $1,101.59 (−13.5%) |
| Likely range | −16.6% … −7.5% |
| As of | 2026-10-26 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Passes |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.